Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Most new moms had their hair grow back within 4-6 months after childbirth, and hair loss is likely due to hormonal changes.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

The document says there are five types of hair loss conditions and different causes, including drugs.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Hair loss in women can be caused by different conditions like hormonal changes, infections, or stress.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Radiation from a medical procedure caused temporary hair loss, but hair regrew with treatment.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

COVID-19 can cause temporary hair loss.

Modern therapies, like fractional laser, effectively treat telogen effluvium.

Weight loss can cause temporary hair loss, especially in women and older adults.

Scalp treatments increased hair density and reduced hair loss in Telogen Effluvium patients.

Different types of hair loss within Telogen Effluvium are caused by various disruptions in hair growth cycles.

COVID-19 may cause hair loss months after infection.

Post-COVID-19 patients are at risk for hair loss.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Collagen CLR and placenta extract may help treat diffuse hair loss.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 often causes hair loss, especially in women.

The document's conclusion cannot be provided because the document cannot be parsed.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Long-term breastfeeding and preterm labor may worsen postpartum hair loss.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Hair loss might be the first sign of dengue fever.

A baby boy had two types of temporary hair loss at birth, which might be two forms of newborn hair loss combined.